Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2023
Committee Review
Apr 2023
Senate Passage
Apr 2023
House Passage
Governor
Introduced Jan 12, 2023
Last action Apr 17, 2023
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
28
Key actions
8
Committee
7
Amendments
3
Apr 17, 2023
Committee
Referred to Public Health
lower
Apr 17, 2023
Introduced
Read first time
lower
Apr 6, 2023
Introduced
Received from the Senate
lower
Apr 5, 2023
Upper · Passed
Passed
upper
Apr 5, 2023
Upper · Passed
Passed to engrossment as amended
upper
Apr 5, 2023
Upper · Passed
Amended
upper
Apr 5, 2023
Introduced
Amendment(s) offered
upper
Mar 31, 2023
Upper · Passed
Committee report printed and distributed
upper
Mar 31, 2023
Upper · Passed
Reported favorably w/o amendments
upper
Mar 29, 2023
Upper · Passed
Vote taken in committee
upper
Mar 22, 2023
Upper · Passed
Left pending in committee
upper
Mar 22, 2023
Upper · Passed
Testimony taken in committee
upper
Feb 15, 2023
Committee
Referred to Health & Human Services
upper
Feb 15, 2023
Introduced
Read first time
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 426
Scope: TX
Hi! I can help you understand SB 426. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline